Tutorial in biostatistics: the self‐controlled case series method

The self-controlled case series method was developed to investigate associations between acute outcomes and transient exposures, using only data on cases, that is, on individuals who have experienced the outcome of interest. Inference is within individuals, and hence fixed covariates effects are implicitly controlled for within a proportional incidence framework. We describe the origins, assumptions, limitations, and uses of the method. The rationale for the model and the derivation of the likelihood are explained in detail using a worked example on vaccine safety. Code for fitting the model in the statistical package STATA is described. Two further vaccine safety data sets are used to illustrate a range of modelling issues and extensions of the basic model. Some brief pointers on the design of case series studies are provided. The data sets, STATA code, and further implementation details in SAS, GENSTAT and GLIM are available from an associated website.

[1]  R. Hubbard,et al.  Risk of myocardial infarction and stroke after acute infection or vaccination. , 2004, The New England journal of medicine.

[2]  R. Hubbard,et al.  General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction , 2005, Heart.

[3]  Robert T. Chen,et al.  Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. , 2004, The New England journal of medicine.

[4]  J P Mullooly,et al.  Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team. , 2000, Archives of family medicine.

[5]  R. L. Prentice,et al.  A case-cohort design for epidemiologic cohort studies and disease prevention trials , 1986 .

[6]  C P Farrington,et al.  Relative incidence estimation from case series for vaccine safety evaluation. , 1995, Biometrics.

[7]  H. Whitaker The self controlled case series method , 2008, BMJ : British Medical Journal.

[8]  M. Maclure The case-crossover design: a method for studying transient effects on the risk of acute events. , 1991, American journal of epidemiology.

[9]  A. Colville,et al.  Risk of aseptic meningitis after measles, mumps,and rubella vaccine in UK children , 1993, The Lancet.

[10]  Robert L Davis,et al.  Safety of the trivalent inactivated influenza vaccine among children: a population-based study. , 2004, Archives of pediatrics & adolescent medicine.

[11]  Liam Smeeth,et al.  Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. , 2003, American journal of epidemiology.

[12]  Robert T. Chen,et al.  Wheezing lower respiratory disease and vaccination of full‐term infants , 2002 .

[13]  R. Hubbard,et al.  Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? , 2003, Thorax.

[14]  Nick Andrews,et al.  Bacterial infections, immune overload, and MMR vaccine , 2003, Archives of disease in childhood.

[15]  U Feldmann,et al.  Epidemiologic assessment of risks of adverse reactions associated with intermittent exposure. , 1993, Biometrics.

[16]  C P Farrington,et al.  Case series analysis of adverse reactions to vaccines: a comparative evaluation. , 1996, American journal of epidemiology.

[17]  Jun Li,et al.  Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association , 1999, The Lancet.

[18]  C P Farrington,et al.  Within‐subject exposure dependency in case‐crossover studies , 2001, Statistics in medicine.

[19]  C P Farrington,et al.  MMR and autism: further evidence against a causal association. , 2001, Vaccine.

[20]  C P Farrington,et al.  Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs. , 2000, American journal of epidemiology.

[21]  E Miller,et al.  No evidence of an association between MMR vaccine and gait disturbance , 2005, Archives of Disease in Childhood.

[22]  Tx Station Stata Statistical Software: Release 7. , 2001 .

[23]  C P Farrington,et al.  Control without separate controls: evaluation of vaccine safety using case-only methods. , 2004, Vaccine.

[24]  Heather J. Whitaker,et al.  Semiparametric analysis of case series data , 2006 .

[25]  M Rush,et al.  A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines , 1995, The Lancet.

[26]  S Greenland,et al.  A unified approach to the analysis of case-distribution (case-only) studies. , 1999, Statistics in medicine.

[27]  E. Miller,et al.  Does oral polio vaccine cause intussusception in infants? Evidence from a sequence of three self-controlled cases series studies in the united kingdom , 2004, European Journal of Epidemiology.

[28]  W. Navidi,et al.  Bidirectional case-crossover designs for exposures with time trends. , 1998, Biometrics.

[29]  N. Andrews,et al.  Statistical assessment of the association between vaccination and rare adverse events post-licensure. , 2001, Vaccine.

[30]  C. P. Farrington,et al.  Lack of association between intussusception and oral polio vaccine in Cuban children , 2004, European Journal of Epidemiology.

[31]  B. Schwartz,et al.  Intussusception among infants given an oral rotavirus vaccine. , 2001, The New England journal of medicine.

[32]  C. Kelman,et al.  The effect of transient exposures on the risk of an acute illness with low hazard rate. , 2004, Biostatistics.

[33]  C P Farrington,et al.  Idiopathic thrombocytopenic purpura and MMR vaccine , 2001, Archives of disease in childhood.

[34]  M Maclure,et al.  Should we use a case-crossover design? , 2000, Annual review of public health.

[35]  C. Lucy Park,et al.  Does Influenza Vaccination Exacerbate Asthma? , 1998, Drug safety.

[36]  U Feldmann Design and analysis of drug safety studies, with special reference to sporadic drug use and acute adverse reactions. , 1993, Journal of clinical epidemiology.

[37]  Thomas Lumley,et al.  Bias in the case – crossover design: implications for studies of air pollution , 2000 .